Azithromycin 500 mg + Ambroxol SR 75 mg Film-Coated Tablet

Azithromycin 500 mg + Ambroxol SR 75 mg Film-Coated Tablet is a film-coated combination tablet formulated with Azithromycin 500 mg + Ambroxol SR 75 mg. The active ingredient profile is Azithromycin; Ambroxol, placing the product in the macrolide antibiotic + mucolytic combination category. Azithromycin provides antibacterial activity, while ambroxol is a mucolytic/expectorant ingredient used to help reduce mucus viscosity and support airway clearance. The sustained-release designation indicates a modified-release presentation and must be described and used exactly according to the approved product literature. For website cataloguing, the composition, strength, dosage form and release/coating characteristics should be displayed prominently and consistently. This product is intended for professional pharmaceutical presentation and should not be described using unapproved efficacy, cure or superiority claims. Clinical selection should depend on the patient, diagnosis, susceptibility or symptom profile, and the prescriber’s judgement. Prescription status, contraindications, precautions, interactions, adverse-effect information and dosing must be checked against the current approved label before publication. Manufacturer, licence, storage, shelf-life, pack configuration and market-specific regulatory details should be added only from verified product documentation.